Annual accounts & ratios
Source: NBB · 2025How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 84.6% | 59.7% | |
| Net result | €125k | €32k | |
| Equity | €381k | €61k | |
| Gross operating margin | €158k | €52k | |
| Total assets | €450k | €127k |
| Fiscal year | 2025 |
|---|---|
| Revenue | — |
| EBITDA | €156k |
| Net profit | €125k |
| Cash flow | €126k |
| Staff costs | — |
| Income taxes | €36k |
| Dividends | — |
| Total assets | €450k |
| Equity | €381k |
| Debt | €69k |
| of which ≤ 1y | €69k |
| of which > 1y | — |
| Working capital | €379k |
| Employees (FTE) | — |
| 2025 | |
|---|---|
| Current ratio | 6.49 |
| Quick ratio | 6.49 |
| Working capital ratio | 84.3% |
| Solvency | 84.6% |
| Debt / equity | 0.18 |
| Long-term debt ratio | — |
| Interest coverage | 1634.31 |
| Gross margin | — |
| Net margin | — |
| ROA | 27.8% |
| ROE | 32.9% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €450k |
| Fixed assets | 21/28 | €2k |
| Tangible fixed assets | 22/27 | €2k |
| Current assets | 29/58 | €449k |
| Amounts receivable within one year | 40/41 | €21k |
| Investments | 50/53 | €58k |
| Cash & bank | 54/58 | €328k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €450k |
| Equity | 10/15 | €381k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €378k |
| Amounts payable | 17/49 | €69k |
| Amounts payable within one year | 42/48 | €69k |
| Trade debts payable within one year | 44 | €20k |
| Income statement | ||
| Gross operating margin | 9900 | €158k |
| Operating result | 9901 | €155k |
| Financial income | 75 | €6k |
| Financial charges | 65 | €96 |
| Result before taxes | 9903 | €161k |
| Income taxes | 67/77 | €36k |
| Net result for the period | 9904 | €125k |
| Result to be appropriated | 9905 | €125k |
Health barometer
FY 2025 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →